Correlation Between Centessa Pharmaceuticals and Kenvue

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Centessa Pharmaceuticals and Kenvue at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Centessa Pharmaceuticals and Kenvue into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Centessa Pharmaceuticals PLC and Kenvue Inc, you can compare the effects of market volatilities on Centessa Pharmaceuticals and Kenvue and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Centessa Pharmaceuticals with a short position of Kenvue. Check out your portfolio center. Please also check ongoing floating volatility patterns of Centessa Pharmaceuticals and Kenvue.

Diversification Opportunities for Centessa Pharmaceuticals and Kenvue

0.36
  Correlation Coefficient

Weak diversification

The 3 months correlation between Centessa and Kenvue is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding Centessa Pharmaceuticals PLC and Kenvue Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kenvue Inc and Centessa Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Centessa Pharmaceuticals PLC are associated (or correlated) with Kenvue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kenvue Inc has no effect on the direction of Centessa Pharmaceuticals i.e., Centessa Pharmaceuticals and Kenvue go up and down completely randomly.

Pair Corralation between Centessa Pharmaceuticals and Kenvue

Given the investment horizon of 90 days Centessa Pharmaceuticals PLC is expected to generate 3.52 times more return on investment than Kenvue. However, Centessa Pharmaceuticals is 3.52 times more volatile than Kenvue Inc. It trades about -0.06 of its potential returns per unit of risk. Kenvue Inc is currently generating about -0.44 per unit of risk. If you would invest  1,819  in Centessa Pharmaceuticals PLC on September 22, 2024 and sell it today you would lose (103.00) from holding Centessa Pharmaceuticals PLC or give up 5.66% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Centessa Pharmaceuticals PLC  vs.  Kenvue Inc

 Performance 
       Timeline  
Centessa Pharmaceuticals 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Centessa Pharmaceuticals PLC are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unsteady basic indicators, Centessa Pharmaceuticals sustained solid returns over the last few months and may actually be approaching a breakup point.
Kenvue Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Kenvue Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Kenvue is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Centessa Pharmaceuticals and Kenvue Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Centessa Pharmaceuticals and Kenvue

The main advantage of trading using opposite Centessa Pharmaceuticals and Kenvue positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Centessa Pharmaceuticals position performs unexpectedly, Kenvue can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kenvue will offset losses from the drop in Kenvue's long position.
The idea behind Centessa Pharmaceuticals PLC and Kenvue Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Other Complementary Tools

Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Stocks Directory
Find actively traded stocks across global markets